Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Lepore

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Translational Vision Science & Technology|August 29, 2020
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW TrialMatthew Fidler, Brian W Fleck, Andreas Stahl, et al.
Scientific Reports|September 4, 2024
Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world studyFederico Giannuzzi, Matteo Mario Carlà, Fabio Margollicci, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 12, 2025
RWC Update: Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors; Giant Macular Hole Leading to a Total Retinal Detachment; Proliferative Sickle Cell Retinopathy: Intraoperative Fluorescein Angiography Guided ManagementAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Turkish Journal of Ophthalmology|February 27, 2023
Avascular Peripheral Retina in InfantsŞengül Özdek, Ece Özdemir Zeydanlı, Caroline Baumal, et al.
Frontiers in Pediatrics|February 28, 2022
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm NeonatesLuciana Teofili, Patrizia Papacci, Martina Bartolo, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 29, 2012
Fluorescein angiography and retinal vascular development in premature infantsVelia Purcaro, Purcaro Velia, Antonio Baldascino, et al.
Therapeutic Advances in Ophthalmology|May 9, 2025
Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatmentAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
JAMA|July 26, 2022
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical TrialAndreas Stahl, Emine A Sukgen, Wei-Chi Wu, et al.
JAMA Network Open|April 30, 2024
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE nextAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
Eye (London, England)|February 9, 2024
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 studyAndreas Stahl, Noriyuki Azuma, Wei-Chi Wu, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Translational Vision Science & Technology|August 29, 2020
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW TrialMatthew Fidler, Brian W Fleck, Andreas Stahl, et al.
Scientific Reports|September 4, 2024
Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world studyFederico Giannuzzi, Matteo Mario Carlà, Fabio Margollicci, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 12, 2025
RWC Update: Management of Persistent Peripheral Avascular Retina in Retinopathy of Prematurity Survivors; Giant Macular Hole Leading to a Total Retinal Detachment; Proliferative Sickle Cell Retinopathy: Intraoperative Fluorescein Angiography Guided ManagementAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Turkish Journal of Ophthalmology|February 27, 2023
Avascular Peripheral Retina in InfantsŞengül Özdek, Ece Özdemir Zeydanlı, Caroline Baumal, et al.
Frontiers in Pediatrics|February 28, 2022
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm NeonatesLuciana Teofili, Patrizia Papacci, Martina Bartolo, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 29, 2012
Fluorescein angiography and retinal vascular development in premature infantsVelia Purcaro, Purcaro Velia, Antonio Baldascino, et al.
Therapeutic Advances in Ophthalmology|May 9, 2025
Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatmentAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
JAMA|July 26, 2022
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical TrialAndreas Stahl, Emine A Sukgen, Wei-Chi Wu, et al.
JAMA Network Open|April 30, 2024
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE nextAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
Eye (London, England)|February 9, 2024
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 studyAndreas Stahl, Noriyuki Azuma, Wei-Chi Wu, et al.
Pageof 5